About The Ensign Group, Inc. 
The Ensign Group, Inc.
Pharmaceuticals & Biotechnology
Ensign Group, Inc., through its operating subsidiaries, provides healthcare services. The Company's operating subsidiaries provide a spectrum of skilled nursing services, physical, occupational and speech therapies and other rehabilitative and healthcare services. The Company operates approximately 231 healthcare operations, 24 of which also include assisted living operations across thirteen states. It operates the healthcare facilities across Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. Through its skilled nursing operations, the Company provides short stay patients and long stay patients with a range of medical, nursing, rehabilitative, pharmacy and routine services, including daily dietary, social and recreational services.
Company Coordinates 
Company Details
29222 Rancho Viejo Rd Ste 127 , SAN JUAN CAPISTRANO CA : 92675-1049
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 119 Schemes (55.75%)
Foreign Institutions
Held by 164 Foreign Institutions (9.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Christopher Christensen
Co-Founder, Executive Chairman and the Chairman of the Board
Mr. Roy Christensen
Chairman Emeritus
Mr. Barry Port
Chief Executive Officer, Director
Ms. Swati Abbott
Independent Director
Dr. Ann Blouin
Independent Director
Mr. Lee Daniels
Independent Director
Mr. Daren Shaw
Independent Director
Revenue and Profits:
Net Sales:
1,228 Million
(Quarterly Results - Jun 2025)
Net Profit:
84 Million
Pharmaceuticals & Biotechnology
USD 10,536 Million (Small Cap)
30.00
NA
0.13%
-0.08
16.09%
5.22






